Golimumab rebate agreements 2026-21

Summary

The tender concerns open-house rebate agreements for medicinal products containing the active substance golimumab. Techniker Krankenkasse intends to conclude agreements with all suitable pharmaceutical companies on uniform terms, without individual negotiations and without exclusivity. The contract term is up to 12 months starting on 01/08/2026 and ends no later than 31/07/2027; it may be extended by another 12 months. The exact participation and contract conditions must be checked in the tender documents.